Aminoglutethimide administration in pregnancy.
D000311:Adrenal Glands / Q000378:metabolism; D000328:Adult; D000450:Aldosterone / Q000652:urine; D000616:Aminoglutethimide / Q000009:adverse effects; D000814:Aniline Compounds / Q000009:adverse effects*; D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects*; D004487:Edema / Q000188:drug therapy; D004967:Estrogens / Q000096:biosynthesis; D005260:Female; D006066:Gonads / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011276:Pregnanediol / Q000652:urine; D011728:Pyridones / Q000009:adverse effects*; D051381:Rats
D000814:Aniline Compounds; D000927:Anticonvulsants; D004967:Estrogens; D011728:Pyridones; D000616:Aminoglutethimide; D000450:Aldosterone; D011276:Pregnanediol